Top Markets
Coin of the day
Cotinga Pharmaceuticals Inc. Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Inc.

COTQF
Ранг среди акций #42319
Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused... Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative treatments for cancer and other medical conditions currently lacking adequate solutions. Its leading therapeutic asset is COTI-2, an oral small molecule formulated to target the p53 tumor suppressor gene. The company is also progressing COTI-219, another oral small molecule compound, specifically engineered to inhibit mutant forms of KRAS without affecting the normal functions of the KRAS gene. In collaboration with St. Vincent's University Hospital, Cotinga is conducting research to evaluate COTI-2 when combined with eribulin for patients suffering from triple-negative metastatic breast cancer. The company, which was previously known as Critical Outcome Technologies Inc., rebranded to Cotinga Pharmaceuticals Inc. in January 2018. Its corporate base is situated in Toronto, Canada.
Цена акции
$0.0001
Последняя синхронизация: 2026-07-02
Рыночная капитализация
$2.20K
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
CA
Торговля Cotinga Pharmaceuticals Inc. (COTQF)

Категория

История дроблений акций Cotinga Pharmaceuticals Inc. (COTQF)
Акции Cotinga Pharmaceuticals Inc. (символ: COTQF) прошли через 0 дроблений.
Последнее дробление произошло Aug 13, 2026.
Одна акция COTQF, купленная до Aug 13, 2026, сейчас соответствует 0 акциям COTQF.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR